Findings
========

Bacterial vaginosis (BV) is one of the most common vaginal disorders of women in reproductive age and is reported to be linked to increased risks of pre-term labor, HIV infection, postoperative infection and inflammatory pelvic disease \[[@B1]\]. It has been recognized that this pathology is caused by a shift in the microbial ecosystem colonizing the vagina of healthy women; from a *Lactobacillus* spp. dominated microbial population to the proliferation of other anaerobic microorganisms such as *Gardnerella vaginalis*, *Atopobium vaginae*, *Mobiluncus* spp. among others \[[@B2]-[@B4]\]. The etiology of BV remains unknown but a recent study reported that microbial biofilms, complex tridimensional structures that are known to be highly resistant to antimicrobial chemotherapy \[[@B5]\], may play a fundamental role in BV \[[@B6]\]. It has been described that *G. vaginalis* may account for 60 to 90% of the BV biofilm mass, while *A. vaginae* may account for 1 to 40% and *Lactobacillus* spp. for 1 to 5% \[[@B7]\]. While trying to confirm these findings, in biofilms from vaginal samples of Portuguese women, using a quantitative PCR approach, we came across some difficulties related with primer specificity, despite the increase in the number of published papers regarding the use of molecular tools, such as PCR, for the detection of BV-associated microorganism \[[@B8]-[@B11]\]. In order to assess the usefulness of the primers for the detection of our target microorganisms used we decided to test the analytical specificity (% of non-target organisms detected) and sensitivity (% of target organisms detected) of the primers used. Being a quick and inexpensive method, *in silico* analysis of primer specificity and sensitibity has been widely used. However this technique poses some limitations, already described for other applications, namelly significant differences between the *in silico* prediction for primer specificity/sensitivity and the actual *in vitro* results \[[@B8],[@B9]\].

To our knowledge the analytical comparison of primer *in silico* and *in vitro* specificity/sensitivity for primers designed for the detection of BV-associated microorganisms has not been studied and with the increase in the use of molecular techniques for the study of BV such information becomes relevant.

We began by selecting primers previously described in the literature specific for *Lactobacillus* spp. \[[@B12],[@B13]\], *G. vaginalis*\[[@B8],[@B14]\] and *A. vaginae*\[[@B11],[@B15]\]. The reported primers specificity was mainly determined by *in silico* analysis using sequence alignment such as BLAST \[[@B16]\]. Whenever *in vitro* specificity was reported, often published details of such specificity determinations were scarce. When confirming primer specificity, using a few collection strains, and the same conditions reported in the literature, we found that some *in silico* primer specificity did not correspond to the *in vitro* specificity (data not shown). To address this, we selected the best primers that we could find in the literature and repeated the *in silico* specificity analysis using ProbeMatch \[[@B17]\]. We also designed new primers (using VectorNTI, version 11.0 and sequences available in the GeneBank databases) (Table [1](#T1){ref-type="table"}).

###### 

***In silico*analysis of primer specificity of the primers used in this study**

  **Target**               **Probe**         **Sequence (5′ → 3′)**   **No. of target strains detected**^**a**^   **Sensitivity (%)**^**b**^   **No. of non-target strains detected**^**a**^   **Specificity (%)**^**b**^   **Reference**
  ---------------------- ------------- ---- ------------------------ ------------------------------------------- ---------------------------- ----------------------------------------------- ---------------------------- ---------------
  *G. vaginalis*          Gard154-454   Fw    CTCTTGGAAACGGGTGGTAA                  36 (from 40)                              90                             1 (from 1032184)                             100                This study
                                        Rv   TTGCTCCCAATCAAAAGCGGT                  38 (from 40)                              95                             94 (from 1032184)                           99,99                     
                            GV1 + 3     Fw   TTACTGGTGTATCACTGTAAGG                                                                                                                                                          \[[@B15]\]
                                        Rv    CCGTCACAGGCTGAACAGT                                                                                                                                                                  
                            Gv1 + 2     Fw    TCCTGTCTACCAAGGCATCC                                                                                                                                                           \[[@B13]\]
                                        Rv    CGTGTGATAACCGTCAGGTG                                                                                                                                                                 
  *A. vaginae*            Atop109-329   Fw    GAGTAACACGTGGGCAACCT                 457 (from 467)                           97,86                          18390 (from 1031757)                          98,22               This study
                                        Rv    CCGTGTCTCAGTCCCAATCT                 449 (from 467)                           96,15                           1356 (from 1031757)                          99,87                     
                           AtovagRT3    Fw    GGTGAAGCAGTGGAAACACT                 134 (from 467)                           28,69                            0 (from 1031757)                             100                \[[@B11]\]
                                        Rv    ATTCGCTTCTGCTCGCGCA                  109 (from 467)                           23,34                            2 (from 1031757)                             100                      
                          Atop167-587   Fw    GCGAATATGGGAAAGCTCCG                 117 (from 467)                           25,05                            0 (from 1031757)                             100                \[[@B10]\]
                                        Rv    TCATGGCCCAGAAGACCGCC                 115 (from 467)                           24,63                            0 (from 1031757)                             100                      
  *Lactobacillus* spp.     AM Lacto     Fw    TGATGCATAGCCGAGTTGAG                7353 (from 12936)                         56,84                           2513 (from 1019288)                          99,75               This study
                                        Rv    AGCCGAAACCCTTCTTCACT                5858 (from 12936)                         45,28                           1027 (from 1019288)                           99,9                     
                           New Lacto    Fw   TGGAAACAGRTGCTAATACCG               11680 (from 12936)                         90,29                           7069 (from 1019288)                          99,31               \[[@B16]\]
                                        Rv    GTCCATTGTGGAAGATTCCC               10113 (from 12936)                         78,18                           3311 (from 1019288)                          99,68                     
                           S21 + A19    Fw   TGCCTAATACATGCAAGTCGA                9754 (from 12936)                          75,4                          184796 (from 1019288)                         81,87               \[[@B17]\]
                                        Rv    GTTTGGGCCGTGTCTCAGT                10157 (from 12936)                         78,52                          72659 (from 1019288)                          92,87                     

Empty boxes correspond to the primers that could not be analysed because there are no databases available to encompass the intergenic region between 16S and 23S rRNA genes for the *in silico* analysis.

^a^Calculated using ProbeMatch (last accession, May 2012) with the following data set options: Strain -- Both; Source -- Both; Size -- \> 1200 bp; Quality -- Both.

^a^Calculated using ProbeMatch (last accession, May 2012) with the following data set options: Strain -- Both; Source -- Both; Size -- \> 1200 bp; Quality -- Both.

^**b**^**Formula**: Specificity = (nts/Tnts)\*100 (nts: **number of non-target strains undetected,** Tnts: **total number of non-target strains tested).**

Sensitivity = (ts/Tts)\*100 (ts: **number of target strains detected,** Tts: **total number of target strains tested).**

During *in silico* analysis of the selected primers, we found two main problems: (i) the selected published primers for *G. vaginalis* were designed for the 16S rRNA-encoding DNA and 23S rRNA-encoding DNA intergenic region \[[@B8],[@B14]\] and there are no available databases which include this region that could be used for the *in silico* analysis; (ii) some of the primers for *A. vaginae* and *Lactobacillus* spp. showed low sensitivity *in silico*. In order to confirm our *in silico* analysis, *in vitro* testing of primer specificity was performed, initially with 3 strains of each target (*G.vaginalis*, *A. vaginae* and *Lactobacillus* spp., details in Additional file [1](#S1){ref-type="supplementary-material"}: Table S1), using DyNAnzyme PCR Master Mix 2x (Finnenzymes, Thermo Scientific, Finland). The initial amplification conditions comprised 40 cycles with the following temperatures each cycle: 94°C for 30 seconds, 60°C for 30 seconds, and 72°C for 1 minute. Amplified products were analysed in a 1% agarose gel and stained with Midori Green nucleic acid dye (Nippon Genetics Europe GmbH, Germany). Results of the PCR at 60°C showed low sensitivity and specificity for *Lactobacillus* spp. primers, and as such we decided to optimize this detection with the aim of obtaining a greater specificity. The annealing temperature was then adjusted to 62°C, and the number of strains increased to a total of 12 target strains (per group) and up to 34 non-target strains (including *Pseudomonas aeruginosa*, *Staphylococcus epidermidis*, *Streptococcus agalactiae*, *Enterococcus faecalis*, *Escherichia coli* and *Staphylococcus cohnii)* (Table [2](#T2){ref-type="table"}). We used different annealing temperatures, in order to observe the effect that this variation would have in primer sensitivity and specificity, which is information that could facilitate the use of these primers in combination (for multiplex PCR assays for example) for quick and effective PCR detection assay.

###### 

***In vitro*analysis of primer specificity of the primers used in this study**

  **Target**               **Probe**    **Annealing temp(°C)**   **No. of target strains detected**^**a**^   **Sensitivity (%)**^**b**^   **No. of non-target strains detected**^**a**^   **Specificity (%)**^**b**^   **Reference**
  ---------------------- ------------- ------------------------ ------------------------------------------- ---------------------------- ----------------------------------------------- ---------------------------- ---------------
  *G. vaginalis*          Gard154-454             60                            3 (from 3)                             100.0                               0 (from 6)                               100.0               This study
                                                  62                           12 (from 12)                            100.0                               0 (from 34)                              100.0                     
                            GV1 + 3               60                             3(from 3)                             100.0                               0 (from 6)                               100.0               \[[@B15]\]
                                                  62                           10 (from 12)                             83.3                               0 (from 34)                              100.0                     
                            Gv1 + 2               60                            3 (from 3)                             100.0                               0 (from 6)                               100.0               \[[@B13]\]
                                                  62                           11 (from 12)                             91.7                               0 (from 34)                              100.0                     
  *A. vaginae*            Atop109-329             60                            3 (from 3)                             100.0                               5 (from 6)                                16.7               This study
                                                  62                           12 (from 12)                            100.0                              15 (from 24)                               37.5                     
                                                  66                           12 (from 12)                            100.0                               3 (from 34)                               91.2                     
                           AtovagRT3              60                           12 (from 12)                            100.0                               1 (from 24)                               95.8               \[[@B11]\]
                                                  62                           12 (from 12)                            100.0                               2 (from 34)                               94.1                     
                          Atop167-587             60                            2 (from 3)                              66.7                               0 (from 6)                               100.0               \[[@B10]\]
                                                  62                           11 (from 12)                             91.6                               4 (from 34)                               88.3                     
  *Lactobacillus spp.*     AM Lacto               60                            2 (from 12)                             16.7                               1 (from 24)                               95.8               This study
                                                  58                            2 (from 12)                             16.7                               3 (from 34)                               91.2                     
                           New Lacto              60                            5 (from 12)                             41.7                              18 (from 34)                               47,1               \[[@B16]\]
                                                  62                            1 (from 12)                             8.3                                8 (from 24)                               66.7                     
                           S21 + A19              60                            5 (from 12)                             41.7                              24 (from 24)                                0                 \[[@B17]\]
                                                  62                            6 (from 12)                             50.0                              34 (from 34)                                0                       

^a^Calculated using ProbeMatch (last accession, May 2012) with the following data set options: Strain -- Both; Source -- Both; Size -- \> 1200 bp; Quality -- Both.

^**b**^**Formula**: Specificity = (nts/Tnts)\*100 (nts: **number of non-target strains undetected,** Tnts: **total number of non-target strains tested).**

Sensitivity = (ts/Tts)\*100 (ts: **number of target strains detected,** Tts: **total number of target strains tested).**

When comparing *in silico* predictions against *in vitro* results, we found considerable differences in specificity and sensitivity values. Despite the fact that theoretical melting temperature of the *A. vaginae* primers designed in this study was 60°C, at this temperature primer specificity was very low. Only with higher annealing temperature (66°C), we could achieve reasonable specificity (91.2%) and sensitivity (100%) values. The primers for *Lactobacillus* spp. were the ones with the lowest specificity. Of note, some of the primers previously reported as specific were found to be non-specific (0%) despite an *in silico* prediction of 81% of specificity. A lower specificity was expected since these primers were designed for the identification of a genus, which results in a higher inherent genetic variability than primers for the identification a species. However, the accentuated decrease between *in silico* and *in vitro* primer specificity was not anticipated. The primers described by Pepin *et al.* (10) revealed the highest specificity for *A. vaginae* (Table [2](#T2){ref-type="table"}), probably due to the previous *in vitro* specificity analysis against at least 20 isolates that was performed by the authors \[[@B10]\]. Although *A. vaginae* primers demonstrated an overall lower specificity, they proved to be highly sensitive, being able to detect all the targets used (Table [2](#T2){ref-type="table"}). It is worth to note that the primer designed for this study for the detection of *G. vaginalis* proved to have a higher sensitivity than that of published primers, and that contrary to the results obtained for the other target microorganisms, the *in silico* prediction of sensitivity and specificity was similar to the *in vitro* results obtained.

It is interesting to note that *in silico* analysis for primers specificity was not a good predictor of *in vitro* primer specificity, something already reported by other researchers \[[@B8],[@B9]\], *in silico* predictions do not take into account the chemical reactions/limitations that can occur in the PCR tube and as such cannot truly approximate experimental events. In most articles describing the detection of BV-associated microorganisms the primer specificity testing is described as being performed *in silico*\[[@B10]-[@B15]\]. This work confirms the importance of proper *in vitro* analysis of primer specificity, as the *in silico* analysis can sometimes underestimate the possible cross reaction with non-sense strains or species which are not yet sequenced, as is the case of most of the strains present in vaginal environment. Furthermore, the new *G. vaginalis* and *A. vaginae* primers reported here have high *in vitro* specificity, demonstrating its potential for use in clinical microbiology.
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